Post Archive by Year

Since many children and about 10% adults have a fear of needles and cite this concern for avoiding vaccines, clinically known as trypanophobia, recent research has identified another immunization option.
Researchers have confirmed that the oral cavity is a convenient location for vaccination and is the target area for an innovative needle-free vaccine.

Amid an expanding outbreak of the chikungunya virus in southeast China, the Guangzhou Wolbaki Biotech Co., Ltd. facility is working to produce five million sterile male mosquitoes per week to disrupt the reproduction chain of disease-carrying mosquitoes.
According to the Company's website on August 14, 2025,  the mosquitoes it cultivates are Wolbachia-infected "sterile males" at the mosquito factory.

ImmunityBio, Inc. today announced that the Michael E. DeBakey Department of Veterans Affairs (VA) Medical Center recently became the first VA hospital in the Houston, Texas, region and one of the first in the U.S. to provide bladder cancer treatment with ANKTIVA®.
A 2024 study found military exposure to carcinogenic agents was associated with a higher risk for bladder cancer among veterans, making this treatment especially vital for those at the VA.

Since the U.S. CDC recommends that international travelers consider getting vaccinated if they are visiting areas experiencing outbreaks of Japanese encephalitis (JE) in 2025, such as India, the only approved vaccine is reporting increased sales.

Since 2006, the U.S. Animal and Plant Health Inspection Service (APHIS) has been collaborating with Panama to establish a barrier zone to prevent the northward spread of New World Screwworms (NWS) in Central and North America.
However, in the past two years, the screwworm has spread beyond the barrier, affecting eastern Panama and reaching Costa Rica, Nicaragua, Honduras, and Guatemala.
And in mid-2025, NWS reached central Mexico.

A recent study led by the University of California, Riverside, and published in Morbidity and Mortality Weekly Reports (74(29);456–462), found that approximately 49% of people are unaware of one or more vaccines recommended for them.
Additionally, 86% of individuals have not received one or more of these vaccines.
This study is the first comprehensive national vaccine surveillance project conducted in emergency departments (ED), which serve as the only access point for healthcare for millions of underserved Americans.

Chikungunya virus (CHIKV) is a challenging mosquito-borne illness that has been detected worldwide in recent years.
Since its rapid spread began in 2004, chikungunya has affected individuals in over 110 countries across Asia, Africa, Europe, and the Americas, including in areas in southeast China this year.
Recent chikungunya outbreaks have been reported in Kenya, Madagascar, Mauritius, Mayotte, Réunion, Somalia, and Sri Lanka.